Research Snappy
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News
No Result
View All Result
Research Snappy
No Result
View All Result

Microsoft Grant for CoVID-19 Research to Shoolini Univ Scientists

researchsnappy by researchsnappy
May 13, 2020
in Healthcare Research
0
399
SHARES
2.3k
VIEWS
Share on FacebookShare on Twitter

SOLAN, India, May 13, 2020 /PRNewswire/ — A team of scientists from Himachal Pradesh-based Shoolini University have been offered a grant through Microsoft Artificial Intelligence for Health Programme to conduct research on finding drugs to cure and prevent CoVID19.

The project has been funded through High Performance Computing (HPC) Consortium, and the team led by Dr Gurjot Kaur, Associate Professor, School of Pharmaceutical Sciences, will have access to Microsoft Azure credits for the next six months to perform work using Microsoft licensed resources, that is, online platform and virtual machines.

The team will perform much-needed screening of phytochemical constituents for anti-viral activity through interaction with CoVID19 specific targets using molecular modeling studies. Indian medicinal herbs have same or similar phytoconstituents and do show great promise as anti-CoVID19 drugs. This project will directly influence the anti-viral drug development for CoVID19 and thus has high impact.

According to Dr Gurjot Kaur, the current number of infected CoVID19 patients is on a rapid rise. While the government has implemented social distancing and a month-long lockdown, these are not good long-term solutions for the spreading pandemic. A more viable idea would be to invest in development of medicinal drugs both for prophylaxis as well as treatment of patients already infected with the virus.

Many existing anti-viral medications are being tried in the hope to slow or even cure the severely affected patients and thus, decrease the morality rate. Unfortunately, none of the current medication strategies are optimum and vaccine development will take more than one year, she added.

Shoolini University Vice Chancellor Prof P K Khosla, lauding the project undertaken by Dr Gurjot Kaur, said that the University would extend all its support for the project.

About Shoolini University:

Set up in 2009, Shoolini University of Biotechnology and Management Sciences is a research-driven private university with full-recognition from the UGC. A leading university of India, it is recognised for its focus on innovation, quality placements, and world-class faculty. Nestled in the lower Himalayas, the university has received accreditation from NAAC and it is ranked by the NIRF.

For further information, please visit: https://shooliniuniversity.com/

Media Contact:
Nishtha Anand
[email protected]
+91-9816637525
Shoolini University

 

Logo – https://mma.prnewswire.com/media/1087576/Shoolini_10_year_logo_Logo.jpg 

Previous Post

Classifieds | Classified advertising | Chicago Reader

Next Post

UK Financier Goldfinch Sets Up New Loan Fund For Film & TV Producers – Deadline

Next Post

UK Financier Goldfinch Sets Up New Loan Fund For Film & TV Producers – Deadline

Research Snappy

Category

  • Advertising Research
  • Consumer Research
  • Data Analysis
  • Healthcare Research
  • Investment Research
  • News
  • Top Company News

HPIN International Financial Platform Becomes a New Benchmark for India’s Digital Economy

Top 10 Market Research Companies in the world

3 Best Market Research Certifications in High Demand

  • Privacy Policy
  • Terms of Use
  • Antispam
  • DMCA
  • Contact Us

© 2025 researchsnappy.com

No Result
View All Result
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News

© 2025 researchsnappy.com